Panic about “HIV” prevention & research funding being slashed by the current administration

There have been a flurry of panicked articles about the new administration canceling funding for “HIV” research, as well as “cuts to ‘HIV’ prevention,” aka the poison of PrEP. We will briefly react to two such articles; there are plenty more where they came from—I think these two are sufficient to give a taste.

Under Trump and RFK Jr., NIH Has Canceled More Than 200 Grants That Fund HIV Research

I love how the publication is named Them. Here we go (emphasis mine throughout):

The National Institutes of Health (NIH) have cancelled over 230 grants funding HIV-related research in the past few weeks, according to an analysis in science journal Nature. The cuts come as Health Secretary Robert F. Kennedy, Jr., planned mass layoffs to drastically alter the size and scope of the Department of Health and Human Services (HHS).

The loss of funding grants for research is certain to impact the nation’s ability to fight its ongoing HIV epidemic. “The likely outcome is going to be a resurgence of HIV,” Julia Marcus, an epidemiologist at Harvard Medical School, told Nature.

What do they mean, “a resurgence of ‘HIV’?” It’s been constant at 0.3% of the U.S. population for forty years; if a resurgence of anything might be likely, one could make a better argument (assuming one buys the HIV AIDS story) that these cuts would lead to a resurgence of AIDS—clearly the resurgence of the clinical syndrome would be objectively worse than the resurgence of the “virus” that even the mainstream has to admit, can lead to AIDS. I think the use of language here is very interesting; Dr. Marcus is concerned specifically about the resurgence of a test result that never went away—how then can it resurge? And why no comment about a resurgence of AIDS, which is manifestly more severe than “HIV” positivity (and is likely not even related to it). That may have been an unintentional tell. Moving on.

Despite cuts to HIV funding, a source told Nature that the administration is “going to continue the very important work to end HIV. That was a big priority of President Trump during the first administration.” Although Trump issued a plan to end HIV in the United States by 2030 during his first term, the actions of his second term do not align with that plan.

No comment. Drop yours below; I just found the quote intriguing. Finally (because I can only take so much of this hand wringing), there is some comment about how “devastating” these cuts will be to “public health”—more like the big Pharma enthusiasts are worried more about the devastation to their bottom line should more people become wise to the extremely lucrative PrEP scam.

Here’s the second piece:

The government is abandoning the fight against HIV. Businesses need to step up & fill the void.

We know how to end new HIV transmissions in the United States. The science is here. We have PrEP to prevent HIV, and we know that for people living with HIV, maintaining an undetectable viral load means they cannot transmit the virus (U=U).

This is probably a good time to point out that “viral load” being “undetectable” means fewer than 20 copies per mL; we have 5000 mL of blood in our body on average—how is this “undetectable?” Of course, because the test isn’t testing for a virus; it’s testing for genetic sequences that are mostly defective, and also overestimated by orders of magnitude via PCR.

This one is interesting to me because he actually throws Trump a bone, which is relevant to the quote above from the first article:

Historically, government leadership has been key to our progress. President Obama introduced the first-ever National HIV/AIDS Strategy for the United States. The Affordable Care Act (Obamacare) expanded healthcare access for people living with or at risk for HIV by eliminating pre-existing condition exclusions and expanding Medicaid to cover millions of previously uninsured, high-risk individuals. In his first term, our current president committed unprecedented resources to the Ending the HIV Epidemic initiative here at home.

As the previous article indicated, there has been no signal that these “unprecedented resources” will continue to be employed. I wonder if RFKJ’s influence has anything to do with this. Most likely we will never know. Wrapping up:

Employers, this is your call to action. Start by making sure your health plans cover PrEP and DoxyPEP. Partner with platforms like MISTR to give employees private, stigma-free access to care. Offer on-site testing. Talk openly about sexual health, not just during Pride, but every day of the year. This is not political — this is about protecting lives, strengthening communities, and building a healthier, more productive workforce. Because healthy employees aren’t just good for public health — they’re good for business.

Public-private partnership is how we end HIV in this country. Government funding laid the foundation. Now, business leaders need to carry the torch forward. When the private sector steps up, outcomes improve.

The idea is to never ever forget about the facade of “HIV” and the “miracle drugs” used to treat it. This whole “never forget” attitude toward “HIV” builds an invisible prison around so many, not only those “retained in care,” but those with completely unreasonable “HIV” anxiety. It’s exhausting, and it’s also dangerous. The U.S. market for PrEP is estimated to be equal to the “HIV” positive population—what a neat trick to double pharma profits.

As always, leave your reaction in the comments.